and New York University $1.67 billion in damages over the infringement of an arthritis- treatment patent by Abbott Laboratories (ABT). The ruling added $175.6 million for prejudgment interest. J&J had alleged that Abbott's rheumatoid arthritis therapy...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Centocor's $1.67 Billion Court Win Versus Abbott Upheld
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account